iRhythm (IRTC) Technologies announced the retirement of two long-serving board members, Mark Rubash and Ralph Snyderman, M.D., effective July 7, 2025. Concurrently, Karen McGinnis and Kevin O’Boyle have accepted appointments to the board of directors. With their appointment to the board of directors, both Mr. O’Boyle and Ms. McGinnis have also been appointed to serve as members of the Company’s Audit Committee, and Mr. O’Boyle will serve as a member of the Nominating & Governance Committee.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRTC:
- iRhythm announces results from two large-scale real-world studies at ADA 2025
- iRhythm price target raised to $165 from $140 at BTIG
- iRhythm management to meet with BTIG
- iRhythm price target raised to $160 from $130 at Morgan Stanley
- Positive Outlook for iRhythm Technologies Driven by Strategic Partnerships and Consistent Growth